日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

CIIE helps Bristol Myers Squibb expand China footprint

By Cao Chen in Shanghai | chinadaily.com.cn | Updated: 2021-06-29 16:33
Share
Share - WeChat
Visitors make inquiries at the stand of Bristol-Myers Squibb during the second China International Import Expo in Shanghai on Nov 9, 2019. [Photo by Lyu Liang/For China Daily]

The China International Import Expo has been a major platform for US biopharmaceutical enterprise Bristol-Myers Squibb to bring its experience in immuno-oncology treatment to the Chinese market and showcase its scientific and innovative achievements, said Chen Siyuan, general manager of Bristol-Myers Squibb China and Hong Kong.

At the third expo held in Shanghai last year, the company unveiled its five-year strategy tailored to the domestic market. The strategy involves accelerating the introduction of nearly 30 innovative drugs to the market, increasing the number of employees in its R&D and commercial teams, growing its investment in China and introducing the latest product lines to China to benefit more patients.

The company also reached a series of agreements with local partners in China at the third CIIE, including a contract with domestic health platform JD Health to establish an online liver disease innovation platform that would improve accessibility of the drug Baraclude, which is used to treat hepatitis B infection of the liver.

Data shows the platform helped raise online sales of the drug, which accounted for 12.5 percent of the company's sales in the first quarter.

A strategic relationship also was established between the company and Hainan Boao Lecheng International Medical Tourism Pilot Zone in South China's Hainan province. According to this partnership, the company's latest products will be first made available in the zone.

The company attended the expo for the first time in 2019 and displayed an immunotherapy drug, Opdivo. According to the company, a Nobel Prize laureate contributed to the development of this drug.

Opdivo has since been approved for use in the treatment of lung cancer, head and neck cancer, and gastric cancer in China.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 国产亚洲久 | 在线 丝袜 欧美 日韩 制服 | 精品久久成人免费第三区 | 国产麻豆剧传媒精品网站 | 米奇精品一区二区三区在线观看 | 日韩男女做性高清在线观看 | 亚洲碰碰| 久久精品.com| 国产乱码一区二区三区 | 成人天堂网 | 九九精品久久久久久噜噜 | 精品国产免费一区二区三区 | 成人免费xxxxx在线观看 | 日日操夜夜操天天操 | 国产福利福利视频 | 极品丝袜高跟91极品系列 | 91看视频 | 日本精品一区二区三区四区 | 国产++欧洲韩国野花视频 | 日韩在线视频观看 | 欧美色性 | 久久香蕉网 | 在线播放av片 | 欧美日屁 | 成人国产在线观看 | 91尤物国产尤物福利 | 国产成人高清视频免费播放 | 国产一区二区三区久久久久久久久 | 暖暖日本在线播放 | 精品在线一区二区 | 在线中文字幕视频 | 91网在线观看| 我爱我色成人网 | 欧美日韩精品一区二区三区四区 | 亚洲成人激情av | 色老师| 91婷婷射 | 五月综合久久 | 欧美一级夜夜爽www 美女污视频网站 | 中文一区| 国产一级做a爰片久久毛片 欧美一区欧美二区 |